Latest Deep Track Capital, LP Stock Portfolio
$6.12Billion | No. of Holdings #62
Deep Track Capital, LP Performance
2026 Q1-2.99%
YTD-2.99%
2025+52.17%
About Deep Track Capital, LP and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Deep Track Capital, LP reported an equity portfolio of $6.1 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of Deep Track Capital, LP are GH, IMVT, TARS. The fund has invested 5% of it's portfolio in GUARDANT HEALTH INC and 4.7% of portfolio in IMMUNOVANT INC . <br><br> The fund managers got completely rid off DYNAVAX TECHNOLOGIES CORP (DVAX), MIND MEDICINE MINDMED INC (MNMD) and ATAI BECKLEY NV (ATAI) stocks. They significantly reduced their stock positions in CYTOKINETICS INC (CYTK), BIOMARIN PHARMACEUTICAL INC (BMRN) and VIRIDIAN THERAPEUTICS INC (VRDN). Deep Track Capital, LP opened new stock positions in ALUMIS INC, NUVALENT INC (NUVL) and GENMAB A/S (GMAB). The fund showed a lot of confidence in some stocks as they added substantially to JANUX THERAPEUTICS INC (JANX), INVENTIVA SA (IVA) and OCULAR THERAPEUTIX INC (OCUL).
Deep Track Capital, LP Equity Portfolio Value
Last Reported on: 15 May, 2026
$6.12Billion
as of May 15, 2026Deep Track Capital, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Deep Track Capital, LP made a return of -2.99% in the last quarter. In trailing 12 months, it's portfolio return was 66.12%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| alumis inc | 149,200,000 |
| nuvalent inc | 141,004,000 |
| genmab a/s | 98,285,000 |
| definium therapeutics inc | 56,700,000 |
| ataibeckley inc | 42,480,000 |
| corvus pharmaceuticals inc | 36,451,200 |
| aclaris therapeutics inc | 35,043,800 |
| veradermics inc | 31,575,000 |
New stocks bought by Deep Track Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| janux therapeutics inc | 1,225 |
| inventiva sa | 149 |
| ocular therapeutix inc | 143 |
| cogent biosciences inc | 120 |
| alkermes plc | 79.52 |
| grail inc | 68.44 |
| compass pathways plc | 65.82 |
| centessa pharmaceuticals plc | 57.9 |
Additions to existing portfolio by Deep Track Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| cytokinetics inc | -58.82 |
| biomarin pharmaceutical inc | -50.00 |
| viridian therapeutics inc | -44.79 |
| apellis pharmaceuticals inc | -41.52 |
| celldex therapeutics inc new | -32.45 |
| cybin inc | -29.18 |
| dyne therapeutics inc | -24.53 |
| maze therapeutics inc | -18.11 |
Deep Track Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| dynavax technologies corp | -241,871,000 |
| atai beckley nv | -19,130,100 |
| mind medicine mindmed inc | -22,448,900 |
| xenon pharmaceuticals inc | -16,423,600 |
| rapt therapeutics inc | -3,740,870 |
| monopar therapeutics inc | -6,230,140 |
| adlai nortye ltd | -49,490 |
Deep Track Capital, LP got rid off the above stocks
Sector Distribution
Deep Track Capital, LP has about 74% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 74 |
| Others | 26 |
Market Cap. Distribution
Deep Track Capital, LP has about 12% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- UNALLOCATED
- SMALL-CAP
- LARGE-CAP
- MICRO-CAP
| Category | % |
|---|---|
| MID-CAP | 41.7 |
| UNALLOCATED | 26 |
| SMALL-CAP | 18.5 |
| LARGE-CAP | 12 |
| MICRO-CAP | 1.5 |
Stocks belong to which Index?
About 55.7% of the stocks held by Deep Track Capital, LP either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 55.7 |
| Others | 44.3 |
Deep Track Capital, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Deep Track Capital, LP
Deep Track Capital, LP has 62 stocks in it's portfolio. About 35.2% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. APLS was the most profitable stock for Deep Track Capital, LP last quarter.
$4.85BTotal Value
69.00Positions
15 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Aclaris Therapeutics Inc Deep Track Capital, LP's holding in Aclaris Therapeutics Inc over time | 0.57% | 9,345,000 | $35.04M 0.57% | Newnew position | |
 Aligos Therapeutics Inc Deep Track Capital, LP's holding in Aligos Therapeutics Inc over time | 0.05% | 444,110 | $3.30M 0.05% | 0%unchanged 0 percentunchanged | |
 Alkermes Plc Alkermes Plc ALKS Deep Track Capital, LP's holding in Alkermes Plc over time | 2.07% | 3,590,320 | $126.95M 2.07% | 79.52%increased 79.52 percentadded | |
 Ani Pharmaceuticals Inc Deep Track Capital, LP's holding in Ani Pharmaceuticals Inc over time | 0.75% | 600,000 | $46.14M 0.75% | 25.61%increased 25.61 percentadded | |
 Apellis Pharmaceuticals Inc Deep Track Capital, LP's holding in Apellis Pharmaceuticals Inc over time | 2.98% | 4,532,370 | $182.34M 2.98% | 41.52%decreased 41.52 percentreduced | |
 Atai Beckley Nv Atai Beckley Nv ATAI Deep Track Capital, LP's holding in Atai Beckley Nv over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Axsome Therapeutics Inc. Deep Track Capital, LP's holding in Axsome Therapeutics Inc. over time | 3.04% | 1,100,000 | $185.92M 3.04% | 4.35%decreased 4.35 percentreduced | |
 Bridgebio Pharma Inc Bridgebio Pharma Inc BBIO Deep Track Capital, LP's holding in Bridgebio Pharma Inc over time | 1.02% | 841,445 | $62.49M 1.02% | 3.86%increased 3.86 percentadded | |
 Beam Therapeutics Inc Deep Track Capital, LP's holding in Beam Therapeutics Inc over time | 0.32% | 820,765 | $19.56M 0.32% | Newnew position | |
 Biomarin Pharmaceutical Inc Deep Track Capital, LP's holding in Biomarin Pharmaceutical Inc over time | 1.06% | 1,150,000 | $64.96M 1.06% | 50%decreased 50 percentreduced | |
 Celldex Therapeutics Inc New Deep Track Capital, LP's holding in Celldex Therapeutics Inc New over time | 0.66% | 1,283,980 | $40.73M 0.66% | 32.45%decreased 32.45 percentreduced | |
 CMPS Compass Pathways Plc Compass Pathways PlcCMPS | 1.1% | 12,161,500 | $67.25M 1.1% | 65.82%increased 65.82 percentadded | |
 Centessa Pharmaceuticals Plc Deep Track Capital, LP's holding in Centessa Pharmaceuticals Plc over time | 2.05% | 3,158,040 | $125.44M 2.05% | 57.9%increased 57.9 percentadded | |
 Context Therapeutics Inc Deep Track Capital, LP's holding in Context Therapeutics Inc over time | 0.32% | 7,419,360 | $19.44M 0.32% | 0%unchanged 0 percentunchanged | |
 Cogent Biosciences Inc Deep Track Capital, LP's holding in Cogent Biosciences Inc over time | 0.63% | 1,000,000 | $38.49M 0.63% | 120.7%increased 120.7 percentadded | |
 Cormedix Inc Cormedix Inc CRMD Deep Track Capital, LP's holding in Cormedix Inc over time | 0.7% | 6,274,080 | $42.60M 0.7% | 18.96%increased 18.96 percentadded | |
 Corvus Pharmaceuticals Inc Deep Track Capital, LP's holding in Corvus Pharmaceuticals Inc over time | 0.6% | 2,491,540 | $36.45M 0.6% | Newnew position | |
 CYBN Cybin Inc Cybin IncCYBN | 0.1% | 1,313,140 | $6.30M 0.1% | 29.18%decreased 29.18 percentreduced | |
 Cytokinetics Inc Cytokinetics Inc CYTK Deep Track Capital, LP's holding in Cytokinetics Inc over time | 1.48% | 1,374,320 | $90.58M 1.48% | 58.82%decreased 58.82 percentreduced | |
 Dynavax Technologies Corp Deep Track Capital, LP's holding in Dynavax Technologies Corp over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |